Neurath MF. Targeting immune cell circuits and trafficking in inflammatory bowel disease. Nat Immunol. 2019;20:970–9.

Article  CAS  PubMed  Google Scholar 

Vuyyuru SK, Kedia S, Sahu P, Ahuja V. Immune-mediated inflammatory diseases of the gastrointestinal tract: beyond Crohn’s disease and ulcerative colitis. JGH Open. 2022;6:100–11.

Article  PubMed  PubMed Central  Google Scholar 

Kim ER, Chang DK. Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis. World J Gastroenterol. 2014;20:9872–81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48:526–35.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Danese S, Vuitton L, Peyrin-Biroulet L. Biologic agents for IBD: practical insights. Nat Rev Gastroenterol Hepatol. 2015;12:537–45.

Article  CAS  PubMed  Google Scholar 

Gaujoux R, Starosvetsky E, Maimon N, Vallania F, Bar-Yoseph H, Pressman S, et al. Cell-centred meta-analysis reveals baseline predictors of anti-TNFalpha non-response in biopsy and blood of patients with IBD. Gut. 2019;68:604–14.

Article  CAS  PubMed  Google Scholar 

Nixon AB, Sibley AB, Liu Y, Hatch AJ, Jiang C, Mulkey F, et al. Plasma protein biomarkers in advanced or metastatic colorectal cancer patients receiving chemotherapy with bevacizumab or cetuximab: results from CALGB 80405 (Alliance). Clin Cancer Res. 2022;28:2779–88.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Krasteva N, Georgieva M. Promising therapeutic strategies for colorectal cancer treatment based on nanomaterials. Pharmaceutics. 2022;14:1213.

Miller KD, Nogueira L, Mariotto AB, Rowland JH, Yabroff KR, Alfano CM, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019;69:363–85.

Article  PubMed  Google Scholar 

Xie YH, Chen YX, Fang JY. Comprehensive review of targeted therapy for colorectal cancer. Signal Transduct Target Ther. 2020;5:22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ma L, Sun P, Zhang JC, Zhang Q, Yao SL. Proinflammatory effects of S100A8/A9 via TLR4 and RAGE signaling pathways in BV-2 microglial cells. Int J Mol Med. 2017;40:31–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chakraborty D, Zenker S, Rossaint J, Holscher A, Pohlen M, Zarbock A, et al. Alarmin S100A8 activates alveolar epithelial cells in the context of acute lung injury in a TLR4-dependent manner. Front Immunol. 2017;8:1493.

Article  PubMed  PubMed Central  Google Scholar 

Meuwis MA, Vernier-Massouille G, Grimaud JC, Bouhnik Y, Laharie D, Piver E, et al. Serum calprotectin as a biomarker for Crohn’s disease. J Crohns Colitis. 2013;7:e678–83.

Article  PubMed  Google Scholar 

Pepper RJ, Hamour S, Chavele KM, Todd SK, Rasmussen N, Flint S, et al. Leukocyte and serum S100A8/S100A9 expression reflects disease activity in ANCA-associated vasculitis and glomerulonephritis. Kidney Int. 2013;83:1150–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boyapati RK, Rossi AG, Satsangi J, Ho GT. Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications. Mucosal Immunol. 2016;9:567–82.

Article  CAS  PubMed  Google Scholar 

Benoit S, Toksoy A, Ahlmann M, Schmidt M, Sunderkotter C, Foell D, et al. Elevated serum levels of calcium-binding S100 proteins A8 and A9 reflect disease activity and abnormal differentiation of keratinocytes in psoriasis. Br J Dermatol. 2006;155:62–6.

Article  CAS  PubMed  Google Scholar 

Shi C, Dawulieti J, Shi F, Yang C, Qin Q, Shi T, et al. A nanoparticulate dual scavenger for targeted therapy of inflammatory bowel disease. Sci Adv. 2022;8:eabj2372.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arevalo-Perez R, Maderuelo C, Lanao JM. Recent advances in colon drug delivery systems. J Control Release. 2020;327:703–24.

Article  CAS  PubMed  Google Scholar 

Kumar R, Islam T, Nurunnabi M. Mucoadhesive carriers for oral drug delivery. J Control Release. 2022;351:504–59.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ren Y, Mu Y, Song Y, Xie J, Yu H, Gao S, et al. A new peptide ligand for colon cancer targeted delivery of micelles. Drug Deliv. 2016;23:1763–72.

Article  CAS  PubMed  Google Scholar 

Kim JS, Kim HK, Kim M, Jang S, Cho E, Mun SJ, et al. Colon-Targeted eNAMPT-Specific Peptide Systems for Treatment of DSS-Induced Acute and Chronic Colitis in Mouse. Antioxidants. 2022;11:2376.

Kim JS, Kim HK, Lee J, Jang S, Cho E, Mun SJ, et al. Inhibition of CD82 improves colitis by increasing NLRP3 deubiquitination by BRCC3. Cell Mol Immunol. 2023;20:189–200.

Article  CAS  PubMed  Google Scholar 

Hsu HH, Chen MC, Baskaran R, Lin YM, Day CH, Lin YJ, et al. Oxaliplatin resistance in colorectal cancer cells is mediated via activation of ABCG2 to alleviate ER stress induced apoptosis. J Cell Physiol. 2018;233:5458–67.

Article  CAS  PubMed  Google Scholar 

Sun W, Ge Y, Cui J, Yu Y, Liu B. Scutellarin resensitizes oxaliplatin-resistant colorectal cancer cells to oxaliplatin treatment through inhibition of PKM2. Mol Ther Oncolytics. 2021;21:87–97.

Article  PubMed  PubMed Central  Google Scholar 

Greenlee JD, Lopez-Cavestany M, Ortiz-Otero N, Liu K, Subramanian T, Cagir B, et al. Oxaliplatin resistance in colorectal cancer enhances TRAIL sensitivity via death receptor 4 upregulation and lipid raft localization. eLife. 2021;10:e67750.

Duan L, Wu R, Ye L, Wang H, Yang X, Zhang Y, et al. S100A8 and S100A9 are associated with colorectal carcinoma progression and contribute to colorectal carcinoma cell survival and migration via Wnt/beta-catenin pathway. PLoS One. 2013;8:e62092.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pu W, Zhang H, Zhang T, Guo X, Wang X, Tang S. Inhibitory effects of Clostridium butyricum culture and supernatant on inflammatory colorectal cancer in mice. Front Immunol. 2023;14:1004756.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baroja-Mazo A, Martin-Sanchez F, Gomez AI, Martinez CM, Amores-Iniesta J, Compan V, et al. The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response. Nat Immunol. 2014;15:738–48.

Article  CAS  PubMed  Google Scholar 

Roh JS, Sohn DH. Damage-associated molecular patterns in inflammatory diseases. Immune Netw. 2018;18:e27.

Article  PubMed  PubMed Central  Google Scholar 

Bresnick AR, Weber DJ, Zimmer DB. S100 proteins in cancer. Nat Rev Cancer. 2015;15:96–109.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Singh P, Ali SA. Multifunctional role of S100 protein family in the immune system: an update. Cells. 2022;11:2274.

Chen QL, Yin HR, He QY, Wang Y. Targeting the NLRP3 inflammasome as new therapeutic avenue for inflammatory bowel disease. Biomed Pharmacother. 2021;138:111442.

Article  CAS  PubMed  Google Scholar 

Bai B, Yang Y, Wang Q, Li M, Tian C, Liu Y, et al. NLRP3 inflammasome in endothelial dysfunction. Cell Death Dis. 2020;11:776.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bauer C, Duewell P, Mayer C, Lehr HA, Fitzgerald KA, Dauer M, et al. Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome. Gut. 2010;59:1192–9.

Article  CAS  PubMed  Google Scholar 

Wang H, Wang X, Zhang H, Deng T, Liu R, Liu Y, et al. The HSF1/miR-135b-5p axis induces protective autophagy to promote oxaliplatin resistance through the MUL1/ULK1 pathway in colorectal cancer. Oncogene. 2021;40:4695–708.

Article  CAS  PubMed  Google Scholar 

Kim YHCAD. Enhanced TLR4 expression on colon cancer cells after chemotherapy promotes cell survival and epithelial–mesenchymal transition through phosphorylation of GSK3β. Anticancer Res. 2016;36:3383–94.

Santaolalla R, Sussman DA, Ruiz JR, Davies JM, Pastorini C, Espana CL, et al. TLR4 activates the beta-catenin pathway to cause intestinal neoplasia. PLoS One. 2013;8:e63298.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Turovskaya O, Foell D, Sinha P, Vogl T, Newlin R, Nayak J, et al. RAGE, carboxylated glycans, and S100A8/A9 play essential roles in colitis-associated carcinogenesis. Carcinogenesis. 2008;29:2035–43.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ichikawa M, Williams R, Wang L, Vogl T, Srikrishna G. S100A8/A9 activate key genes and pathways in colon tumor progression. Mol Cancer Res. 2011;9:133–48.

Article  CAS  PubMed  PubMed Central